Cargando…

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis

BACKGROUND: The estimated prevalence of comorbid major depressive disorder (. MDD) is 11% in patients with type 2 diabetes (T2D) and 15–20% in those with cardiovascular disease (CVD). Comorbid MDD continues to be a significant source of economic burden to the healthcare system. METHODS: We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kangethe, Anne, Lawrence, Debra F., Touya, Maëlys, Chrones, Lambros, Polson, Michael, Evangelatos, Themmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349073/ https://www.ncbi.nlm.nih.gov/pubmed/34362353 http://dx.doi.org/10.1186/s12913-021-06802-9

Ejemplares similares

Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data
por: Touya, Maëlys, et al.
Publicado: (2022)

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
por: Mattingly, Gregory, et al.
Publicado: (2023)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune, Bernhard T, et al.
Publicado: (2021)

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
por: Jacobsen, Paula L., et al.
Publicado: (2015)

O8.5. SCHIZOPHRENIA AND BIPOLAR DISORDER DIAGNOSIS PATTERNS: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
por: Saragoussi, Delphine, et al.
Publicado: (2018)

Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
por: Yan, Tingjian, et al.
Publicado: (2018)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi, Delphine, et al.
Publicado: (2017)

Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients
por: Qureshi, Zaina P., et al.
Publicado: (2021)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
por: Kimball, Alexandra B., et al.
Publicado: (2018)

The incremental burden of pain in patients with depression: results of a Japanese survey
por: Vietri, Jeffrey, et al.
Publicado: (2015)

Depression and cardiovascular comorbidity
por: Glassman, Alexander H.
Publicado: (2007)

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2019)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
por: Ezzedine, Khaled, et al.
Publicado: (2023)

Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis
por: Pilon, Dominic, et al.
Publicado: (2021)

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
por: McIntyre, Roger S, et al.
Publicado: (2022)

High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex
por: Albrecht, Katinka, et al.
Publicado: (2023)

Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
por: Trefz, K. F., et al.
Publicado: (2019)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul, Papan, et al.
Publicado: (2014)

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor
por: Tsai, Max, et al.
Publicado: (2016)

Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases
por: Touya, Maëlys, et al.
Publicado: (2019)

Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set
por: Walsh, Jessica A., et al.
Publicado: (2018)

Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA
por: Greene, Mallik, et al.
Publicado: (2018)

Results and validation of an index to measure health state of patients with depression in automated healthcare databases
por: Lamy, François-Xavier, et al.
Publicado: (2019)

Gender differences in cardiovascular disease and comorbid depression.
por: Möller-Leimkühler, Anne Maria
Publicado: (2007)

Comorbid Major Depressive Disorder and Obstructive Sleep Apnea
por: Chinvararak, Chotiman, et al.
Publicado: (2022)

Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany
por: Christensen, Stefan, et al.
Publicado: (2019)

Distinct biological signature and modifiable risk factors underly the comorbidity between major depressive disorder and cardiovascular disease
por: Bergstedt, Jacob, et al.
Publicado: (2023)

Cancer—A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
por: Finke, Daniel, et al.
Publicado: (2021)

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey
por: Raveendran, Subhara, et al.
Publicado: (2023)

Incremental healthcare cost burden in patients with atrial flutter only
por: Kim, Kathryn M., et al.
Publicado: (2023)

Polygenic loading for major depression is associated with specific medical comorbidity
por: McCoy, T H, et al.
Publicado: (2017)

Well-being in major depression and social phobia with and without comorbidity
por: Wersebe, Hanna, et al.
Publicado: (2018)

Comorbid Anxiety and Suicidal Behaviors in American Adolescents With Major Depression
por: Mathialagan, Keerthika, et al.
Publicado: (2020)

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression
por: Ueda, Masashi, et al.
Publicado: (2020)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem, Caitlyn T, et al.
Publicado: (2016)

Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims Analysis
por: Schein, Jeff, et al.
Publicado: (2023)

Emotion Regulation Deficits in Adolescent Girls with Major Depression, Anorexia Nervosa and Comorbid Major Depression and Anorexia Nervosa
por: Zsigo, Carolin, et al.
Publicado: (2022)

Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
por: Ma, Qiufei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lsqfdrqnistdj652b10mghsn3c